Immutep Limited Asset Turnover Ratio (IMMP), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Immutep Limited  (NASDAQ: IMMP)
 

Immutep Limited Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Immutep Limited asset turnover ratio, the ability of Immutep Limited's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.09 in the fourth quarter (Jun 30 2025), yet the ratio remained below the average, as IMMP's position remain challenging.

Within sector 5 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the IV Quarter 2025, to 149, from total ranking in the third quarter 2025 at 2243.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IMMP Asset Turnover Ratio (Jun 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Jun 30 2024)
IV. Quarter
Y / Y Asset Change -23.34 % -23.34 % -23.12 % -21.68 % 37 %
Y / Y Revenue Change 31.8 % - - - 50.74 %
Asset Turnover Ratio (TTM) 0.09 - - - 0.05
IMMP's Total Ranking # 149 # 2243 # # #
Seq. Asset Change 0 % 0.34 % -34.23 % 16.17 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 16
Overall Market # 149

Asset Turnover Ratio Statistics
High Average Low
88.58 23.8 2.06
(Jun 30 2025)   (Jun 30 2023)




IMMP Company Profile • Back to IMMP Efficiency Comparisons • Compare IMMP Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2025 Assets at quarter ending Jun 30 2025
Mersana Therapeutics inc   0.27 $ 34.769  Millions$ 127.809  Millions
Bridgebio Pharma Inc   0.27 $ 235.812  Millions$ 886.536  Millions
Kyntra Bio Inc   0.26 $ 53.555  Millions$ 205.553  Millions
Bio rad Laboratories Inc   0.26 $ 2,554.115  Millions$ 9,927.143  Millions
Cryoport inc   0.26 $ 184.343  Millions$ 719.757  Millions
Iovance Biotherapeutics inc   0.26 $ 241.525  Millions$ 943.930  Millions
Standard Biotools Inc   0.25 $ 154.535  Millions$ 607.611  Millions
Fulgent Genetics Inc   0.25 $ 303.401  Millions$ 1,214.827  Millions
Tenon Medical Inc   0.25 $ 2.947  Millions$ 11.848  Millions
Retractable Technologies Inc  0.24 $ 37.609  Millions$ 153.732  Millions
Adc Therapeutics Sa  0.24 $ 77.246  Millions$ 316.290  Millions
Cue Biopharma Inc   0.24 $ 8.287  Millions$ 34.991  Millions
Repligen Corp  0.24 $ 673.956  Millions$ 2,853.520  Millions
X4 Pharmaceuticals Inc  0.23 $ 32.774  Millions$ 139.948  Millions
Invo Fertility Inc   0.23 $ 6.620  Millions$ 28.633  Millions
Cyclerion Therapeutics Inc   0.23 $ 2.174  Millions$ 9.423  Millions
Dariohealth Corp   0.23 $ 25.925  Millions$ 113.191  Millions
Arcus Biosciences Inc   0.23 $ 262.000  Millions$ 1,158.250  Millions
Moderna Inc   0.23 $ 3,078.000  Millions$ 13,664.750  Millions
Revvity Inc  0.22 $ 2,798.467  Millions$ 12,471.432  Millions
Jaguar Health Inc   0.22 $ 11.810  Millions$ 52.905  Millions
Universal Biosensors Inc   0.22 $ 5.255  Millions$ 23.966  Millions
Neogen Corporation  0.22 $ 894.376  Millions$ 4,133.045  Millions
Lipocine Inc   0.21 $ 4.346  Millions$ 20.571  Millions
Profound Medical Corp   0.21 $ 11.840  Millions$ 56.180  Millions
Theravance Biopharma inc   0.21 $ 77.205  Millions$ 369.971  Millions
Maravai Lifesciences Holdings Inc   0.21 $ 215.853  Millions$ 1,035.794  Millions
Lexicon Pharmaceuticals Inc   0.20 $ 58.432  Millions$ 285.699  Millions
Xoma Royalty Corporation  0.20 $ 44.952  Millions$ 220.206  Millions
Ligand Pharmaceuticals Incorporated  0.20 $ 187.388  Millions$ 937.670  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.